|
BTBD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.341200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.648800E-01 |
| Normal-vs-Stage2 |
2.664000E-02 |
| Normal-vs-Stage3 |
5.420100E-02 |
| Normal-vs-Stage4 |
1.364850E-01 |
| Stage1-vs-Stage2 |
2.957100E-03 |
| Stage1-vs-Stage3 |
6.398200E-02 |
| Stage1-vs-Stage4 |
2.277000E-01 |
| Stage2-vs-Stage3 |
1.376620E-04 |
| Stage2-vs-Stage4 |
1.562450E-03 |
| Stage3-vs-Stage4 |
8.415800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.596190E-01 |
| Normal-vs-AfricanAmerican |
6.906600E-01 |
| Normal-vs-Asian |
9.796600E-01 |
| Caucasian-vs-AfricanAmerican |
2.428800E-01 |
| Caucasian-vs-Asian |
3.051800E-01 |
| AfricanAmerican-vs-Asian |
7.328000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.148800E-01 |
| Normal-vs-Female |
5.427600E-01 |
| Male-vs-Female |
9.635000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.596600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.445800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.902800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.789900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.091200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.521400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.258100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.551200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.856000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.709600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.384800E-04 |
| Classical-VS-Follicular |
4.735000E-03 |
| Classical-VS-Other |
3.931600E-01 |
| Classical-VS-Normal |
5.192600E-01 |
| Tall-VS-Follicular |
2.19360000053292E-07 |
| Tall-VS-Other |
4.209200E-01 |
| Tall-VS-Normal |
4.998300E-04 |
| Follicular-VS-Other |
1.169020E-01 |
| Follicular-VS-Normal |
5.297600E-02 |
| Other-VS-Normal |
1.997030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.837400E-01 |
| Normal-vs-N1 |
4.115900E-02 |
| N0-vs-N1 |
2.766100E-02 |
|
|
